← FDA Drug Approvals (Drugs@FDA)
OXYBUTYNIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BARR LABS DIV TEVA · Approved 2014-03-04
Drug application
- FDA Application #
ANDA090526- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXYBUTYNIN
- Generic name
- Oxybutynin
- Active ingredients
- OXYBUTYNIN
- Dosage form
- FILM, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Marketing status
- Discontinued
- Sponsor
- BARR LABS DIV TEVA
- First approval
- 2014-03-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown